Benny Boy, NYR also had a drug "far superior" for cholesterol, but do you know how that ended?
NYR-BI03 is the plan B, a bit of an afterthought. It was originally there so they could boast about having a "pipeline" - no one thought it would have to be the company maker.
So now, unfortunately, NYR are a one trick pony - one bad GLP result away from complete desolation. And no matter how much you compulsively post your nonsense about "proven safety in humans" and "100000 trillion dollar valuation", the facts don't lie.
We know a CR is coming very soon. Why, the very subject of this thread is an updated Investor deck, which is a pretty big clue. And honestly, they would be crazy not to try and raise at these current ridiculous prices, which seem to be precipitated on one vaguely defined mouse study and a rather excitable Kyriaco propping up the SP.
NYR Price at posting:
10.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)